Why Methylene Blue Is the Only Option for Blocking the cGMP/NO Pathway in The Treatment of Vasoplegic Shock? "Reasons That Reason Itself Does Not Know&#8230;"

Department of Surgery and Anatomy Ribeirão Preto School of MedicineEvora, Paulo Roberto B.; Gomes, Walter J

Why Methylene Blue Is the Only Option for Blocking the cGMP/NO Pathway in The Treatment of Vasoplegic Shock? "Reasons That Reason Itself Does Not Know…"

Department of Surgery and Anatomy Ribeirão Preto School of MedicineEvora, Paulo Roberto B.; Gomes, Walter J.

Department of Surgery and Anatomy Ribeirão Preto School of MedicineEvora, Paulo Roberto B.; Universidade de São Paulo. Faculdade de Medicina de Ribeirão Preto. Department of Surgery and Anatomy Ribeirão Preto School of MedicineEvora, Paulo Roberto B.. Ribeirão Preto. BR
Gomes, Walter J; Federal University of São Paulo. Escola Paulista de Medicina. Cardiovascular Surgery Discipline and São Paulo Hospital. São Paulo. BR

Rev. bras. cir. cardiovasc ; 36(3): I-II, May-June 2021.

Article in English | LILACS | ID: biblio-1288247

Subject(s)

Humans; Shock/drug therapy; Methylene Blue/therapeutic use; Cardiopulmonary Bypass

Fulltext

XML

Search on Google

Full text: Available Index: LILACS (Americas) Main subject: Shock / Methylene Blue Limits: Humans Language: English Journal: Rev. bras. cir. cardiovasc Journal subject: Cardiology / General Surgery Year: 2021 Type: Article Affiliation country: Brazil Institution/Affiliation country: Federal University of São Paulo/BR / Universidade de São Paulo/BR

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

Search on Google